
A proportion of patients with fibrotic hypersensitivity pneumonitis have high mortality, and short‐term predictors of poorer survival are needed. Declines from baseline at 1 year in forced vital capacity (FVC) ≥ 10% and diffusion capacity of the lung for carbon monoxide (DLCO) ≥ 15%, but also marginal declines in FVC ≥ 5% and DLCO ≥ 10%, are predictive of increased mortality. A proportion of patients with fibrotic hypersensitivity pneumonitis (fHP) follow a progressive disease course despite immunosuppressive treatment. Little is known about predictors of mortality in fHP. We aimed to investigate the impact of short‐term lung function changes in fHP on mortality...
Like
Save
Share